Back to GEODE CAPITAL MANAGEMENT, LLC GEODE CAPITAL MANAGEMENT, LLC

JANXJANX
21 quarters

Position history for GEODE CAPITAL MANAGEMENT, LLCGEODE CAPITAL MANAGEMENT, LLC's holdings in JANUX THERAPEUTICS INC

Yes. Geode Capital Management holds 1,204,150 shares of JANX (Janux Therapeutics), worth $18.5M, as of its Q2 2026 13F filing. It increased the position by 57,426 shares (+5.0%) from Q1 2026. Geode Capital Management has held JANX since Q2 2021, across 21 quarterly 13F filings.

Current Value

$18.5M

Current Shares

1.2M

Total Value Change

+$18M

Total Shares Change

+1.2M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.2M
+5.0%
$18.5M0.0%$15.36
30
2026-Q1
Increased
1.1M
+3.0%
$15.9M0.0%$13.44
29
2025-Q4
Increased
1.1M
+2.7%
$15.4M0.0%$13.83
29
2025-Q3
Increased
1.1M
+20.1%
$26.5M0.0%$23.70
34
2025-Q2
Increased
902,312
+15.6%
$20.8M0.0%$23.15
33
2025-Q1
Increased
780,909
+9.2%
$21.1M0.0%$29.10
31
2024-Q4
Increased
714,956
+7.9%
$38.3M0.0%$52.50
31
2024-Q3
Increased
662,594
+6.2%
$30.1M0.0%$46.25
31
2024-Q2
Increased
624,104
+33.5%
$26.1M0.0%$41.89
37
2024-Q1
Increased
467,547
+14.5%
$17.6M0.0%$37.65
32
2023-Q4
Increased
408,190
+5.5%
$4.4M0.0%$10.73
28
2023-Q3
Increased
386,804
+2.5%
$3.9M0.0%$10.08
27
2023-Q2
Increased
377,225
+6.4%
$4.5M0.0%$11.53
29
2023-Q1
Increased
354,585
+4.3%
$4.3M0.0%$11.60
28
2022-Q4
Increased
339,797
+1.6%
$4.5M0.0%$13.17
27
2022-Q3
Increased
334,521
+17.9%
$4.5M0.0%$13.37
31
2022-Q2
Increased
283,620
+3.0%
$3.5M0.0%$11.44
27
2022-Q1
Increased
275,231
+24.8%
$3.9M0.0%$14.57
33
2021-Q4
Increased
220,527
+4.1%
$4.4M0.0%$19.89
28
2021-Q3
Increased
211,880
+862.4%
$4.6M0.0%$22.93
43
2021-Q2
New
22,017
-
$549,0000.0%$25.37
34

Other major holders of JANX: RA CAPITAL MANAGEMENT, L.P., FMR LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used